CRISPR Therapeutics CRSP
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$21.27M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 36.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 19.39% to 17.78% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Carne Global Fund Managers Ireland Limited | Mutual Fund | 2026/Q3 | +49,020 | 0.1% |
| Samarth Kulkarni | Individual/Insider | 2026/Q3 | +56,398 | 0.3% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +672,381 | 5.1% |
| ARK Investment Management LLC | Mutual Fund | 2026/Q3 | +595,905 | 10.4% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +136,379 | 0.2% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +65,335 | 0.1% |
| NTV Asset Management, LLC | Mutual Fund | 2026/Q3 | +61,443 | 0.1% |
| Barclays PLC | Public Company | 2026/Q3 | +46,168 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +79,519 | 0.2% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +893,812 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +668,904 | 8.6% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +505,570 | 2.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +339,166 | 4.5% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +300,000 | 0.3% |
| Morgan Stanley | Public Company | 2026/Q3 | +185,927 | 0.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 5 Nov 2026 | Raju Prasad | Officer | Intent to Sell (Form 144) | -79,393 | $49.88 | – |
| 3 Nov 2026 | Sivakesava Sakhamuri | Chief Technology Officer | Other Derivative Acquisition | +40,000 | – | 40,000 |
| 3 Nov 2026 | Sivakesava Sakhamuri | Chief Technology Officer | Other Derivative Acquisition | +90,000 | $51.78 | 90,000 |
| 25 Oct 2026 | Samarth Kulkarni | Chairperson & CEO | Other Derivative Acquisition | +28,750 | – | 28,750 |
| 25 Oct 2026 | Samarth Kulkarni | Chairperson & CEO | Other Derivative Acquisition | +57,500 | $49.01 | 57,500 |
| 25 Oct 2026 | Naimish Patel | Chief Medical Officer | Other Derivative Acquisition | +12,000 | – | 12,000 |
| 25 Oct 2026 | Naimish Patel | Chief Medical Officer | Other Derivative Acquisition | +24,000 | $49.01 | 24,000 |
| 25 Oct 2026 | James Kasinger | General Counsel | Other Derivative Acquisition | +9,000 | – | 9,000 |
| 25 Oct 2026 | James Kasinger | General Counsel | Other Derivative Acquisition | +18,000 | $49.01 | 18,000 |
| 25 Oct 2026 | Andrew Silver | CFO, Principal Financial Officer & Principal Accounting Officer | Other Derivative Acquisition | +9,000 | – | 9,000 |
| 25 Oct 2026 | Andrew Silver | CFO, Principal Financial Officer & Principal Accounting Officer | Other Derivative Acquisition | +18,000 | $49.01 | 18,000 |
| 18 Oct 2026 | Andrew Silver | CFO, Principal Financial Officer & Principal Accounting Officer | Other Derivative Acquisition | +25,000 | – | 25,000 |
| 18 Oct 2026 | Andrew Silver | CFO, Principal Financial Officer & Principal Accounting Officer | Initial Statement of Beneficial | +0 | – | 85,374 |
| 18 Oct 2026 | Samarth Kulkarni | Chairperson & CEO | Derivative Exercise and Sale | -47,837 | $49.78 | 311,899 |
| 15 Oct 2026 | Samarth Kulkarni | Chairperson & CEO | Derivative Exercise and Retained | +52,163 | – | 311,899 |
| 13 Oct 2026 | Simeon George | Independent Director | Derivative Exercise and Sale | -14,514 | $49.63 | 15,486 |
| 13 Oct 2026 | Simeon George | Independent Director | Derivative Exercise and Retained | +15,486 | $14.00 | 15,486 |
| 13 Oct 2026 | Samarth Kulkarni | Chairperson & CEO | Derivative Exercise and Sale | -4,098 | $49.26 | 259,736 |
| 13 Oct 2026 | James Kasinger | General Counsel | Derivative Exercise and Sale | -1,040 | $49.26 | 95,857 |
| 12 Oct 2026 | Samarth Kulkarni | Chairperson & CEO | Derivative Exercise and Retained | +4,235 | – | 259,736 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 17,189,067 | 17.8% | 13.1 |
| 15 Oct 2026 | 16,442,415 | 17.0% | 10.2 |
| 30 Sep 2026 | 18,679,198 | 19.3% | 9.6 |
| 15 Sep 2026 | 19,071,093 | 19.7% | 16.5 |
| 31 Aug 2026 | 18,769,995 | 19.4% | 10.7 |
| 14 Aug 2026 | 18,744,855 | 19.4% | 15.6 |
No comments yet — be the first to weigh in on CRSP.
Sign in to join the discussion.